Atai Life Sciences
ATAI • NASDAQ • Stock Fundamentals
Atai Life Sciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Christian Angermayer, with a market cap of $1.6B.
Market Cap$1.6B
Employees83.0
CEOChristian Angermayer
CountryGermany
Healthcare
Biotechnology
Most Recent EarningsMay 12, 2026 · 16 days agoQ1 2026
View reportNext EarningsAug 13, 2026 · in 3 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Atai Life Sciences FAQ
Common questions about Atai Life Sciences
Atai Life Sciences (ATAI) has a market capitalization of $1.6B and trades on NASDAQ.
Atai Life Sciences has approximately 83 employees.